Connective Capital Management LLC Purchases Shares of 52,899 LifeMD, Inc. (NASDAQ:LFMD)

Connective Capital Management LLC purchased a new stake in LifeMD, Inc. (NASDAQ:LFMD – Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 52,899 shares of the company’s stock, valued at approximately $363,000. LifeMD makes up approximately 0.7% of Connective Capital Management LLC’s [...]

featured-image

Connective Capital Management LLC purchased a new stake in LifeMD, Inc. ( NASDAQ:LFMD – Free Report ) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 52,899 shares of the company’s stock, valued at approximately $363,000.

LifeMD makes up approximately 0.7% of Connective Capital Management LLC’s investment portfolio, making the stock its 22nd largest holding. Connective Capital Management LLC owned approximately 0.



13% of LifeMD at the end of the most recent quarter. Several other institutional investors and hedge funds also recently modified their holdings of the company. Quest Partners LLC bought a new stake in LifeMD during the 2nd quarter worth about $31,000.

Los Angeles Capital Management LLC acquired a new stake in shares of LifeMD in the second quarter valued at about $88,000. EntryPoint Capital LLC bought a new stake in LifeMD during the first quarter worth about $89,000. The Manufacturers Life Insurance Company acquired a new position in LifeMD during the second quarter valued at approximately $93,000.

Finally, XTX Topco Ltd bought a new position in LifeMD in the second quarter valued at approximately $94,000. 35.52% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In LFMD has been the topic of several recent analyst reports. Cantor Fitzgerald restated an “overweight” rating and set a $15.00 price objective on shares of LifeMD in a research note on Friday, September 20th.

KeyCorp reduced their price target on LifeMD from $12.00 to $10.00 and set an “overweight” rating for the company in a report on Thursday, July 11th.

Finally, B. Riley assumed coverage on LifeMD in a research note on Friday, August 23rd. They issued a “buy” rating and a $11.

00 price objective on the stock. Six research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $12.00.

LifeMD Price Performance LifeMD stock opened at $5.21 on Monday. The firm has a market cap of $217.

55 million, a PE ratio of -7.04 and a beta of 1.19.

The company has a debt-to-equity ratio of 10.83, a current ratio of 0.87 and a quick ratio of 0.

83. The stock’s fifty day moving average price is $5.55 and its two-hundred day moving average price is $7.

72. LifeMD, Inc. has a one year low of $4.

65 and a one year high of $12.88. LifeMD ( NASDAQ:LFMD – Get Free Report ) last announced its quarterly earnings data on Wednesday, August 7th.

The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.13) by ($0.

06). The business had revenue of $50.66 million for the quarter, compared to analysts’ expectations of $48.

47 million. During the same quarter last year, the firm earned ($0.23) EPS.

As a group, research analysts expect that LifeMD, Inc. will post -0.49 EPS for the current fiscal year.

LifeMD Profile ( Free Report ) LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. See Also Five stocks we like better than LifeMD Why Are These Companies Considered Blue Chips? Top 5 ETFs to Own Now and Into 2025 There Are Different Types of Stock To Invest In Watch These 3 Former Short-Squeeze Stocks for a Big Rally What Are the FAANG Stocks and Are They Good Investments? Simon Property REIT: A Safe Bet for Growth and Steady Dividends Want to see what other hedge funds are holding LFMD? Visit HoldingsChannel.

com to get the latest 13F filings and insider trades for LifeMD, Inc. ( NASDAQ:LFMD – Free Report ). Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.

com's FREE daily email newsletter ..